Previous close | 1.3800 |
Open | 1.3300 |
Bid | 1.2500 |
Ask | 1.3100 |
Strike | 5.00 |
Expiry date | 2025-01-17 |
Day's range | 1.3100 - 1.3300 |
Contract range | N/A |
Volume | |
Open interest | 14.78k |
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID vaccine induces a more robust immune response compared with its previously approved bivalent COVID vaccine.
Novavax, Inc. ( NASDAQ:NVAX ) missed earnings with its latest full-year results, disappointing overly-optimistic...
Novavax ( NASDAQ:NVAX ) Full Year 2023 Results Key Financial Results Revenue: US$983.7m (down 50% from FY 2022). Net...